SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-008131
Filing Date
2015-02-12
Accepted
2015-02-12 06:20:23
Documents
4
Period of Report
2015-02-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v401350_8k.htm 8-K 38212
2 EXHIBIT 1.1 v401350_ex1-1.htm EX-1.1 273357
3 EXHIBIT 4.1 v401350_ex4-1.htm EX-4.1 139190
4 EXHIBIT 5.1 v401350_ex5-1.htm EX-5.1 14469
  Complete submission text file 0001144204-15-008131.txt   466442
Mailing Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080 650 474 8200
THRESHOLD PHARMACEUTICALS INC (Filer) CIK: 0001183765 (see all company filings)

IRS No.: 943409596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32979 | Film No.: 15601838
SIC: 2834 Pharmaceutical Preparations